DA SPOT NYC - CNBC Interview on Phase 1 Reopening
Watch CNBC's full interview with Teva CEO Kåre Schultz
McAfee Rebuts Dimon: Crypto-Currencies 'Not a Fraud' | Barron's
Teva Pharma among IQ100 leaders
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
New & Notable: Amazon tablets, Samsung laptops, Teva sandals
Teva stock plummets 18% after rough quarter in US generic drug market
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
News of Note—Teva strikes labor agreement at Israeli plant | Fierce Pharma
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Irit Ron - Materials Master Data analyst - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals - Crunchbase Company Profile & Funding
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Cramer shocked by Buffett's investment in "second-rate" Teva - Globes
M·CAM | News & Events
Teva's proposed opioid settlement could cost drugmaker pennies on the dollar
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
A Look At Kare Schultz, The New CEO In Charge Of Teva
CNBC-TV18 on Twitter: "Indoco Remedies targets getting back to 20% margin. Talking about the partnership with Teva, co says it's a profit sharing arrangement for Azopt Generic https://t.co/U9Ehvy6VJV" / Twitter
Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround
CNBC on Twitter: "BREAKING: Warren Buffett's Berkshire Hathaway takes stake in Teva Pharma.; stock jumps after-hours. https://t.co/YKho1O67Ek https://t.co/bn0ijczjFc" / Twitter
DiversityInc - CEO Luke Visconti on CNBC's "Closing Bell" | Facebook
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Teva: Leverage A Concern (NYSE:TEVA) | Seeking Alpha
